The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnteq Tech Regulatory News (NTQ)

Share Price Information for Enteq Tech (NTQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.00
Bid: 8.50
Ask: 9.50
Change: 0.00 (0.00%)
Spread: 1.00 (11.765%)
Open: 9.00
High: 9.00
Low: 9.00
Prev. Close: 9.00
NTQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Awards under the Enteq Performance Share Plan

23 Oct 2023 07:00

RNS Number : 8857Q
Enteq Technologies PLC
23 October 2023
 

Enteq Technologies plc

("Enteq" or the "Company")

Awards under the Enteq Technologies plc Performance Share Plan ("PSP")

Enteq Technologies plc (AIM: NTQ.L), the energy services technology and equipment supplier announces that its Remuneration Committee has approved a grant of awards under its Performance Share Plan ("PSP") effective on 20 October 2023.

This grant has a vesting date of 20 October 2026. The vesting performance condition relates to the achievement of a total shareholder return target over the period to 31 March 2026. This target is set and monitored by the Remuneration Committee. The consideration payable for these awards on exercise is 1 pence per ordinary share in the Company ("Ordinary Share"). Under the terms of the PSP these awards are subject to claw back and malus provisions, and no holding period.

Andrew Law (CEO) was granted PSP options over 1,184,211 Ordinary Shares, taking his total outstanding grants under the PSP scheme to options over 2,593,876 Ordinary Shares.

Mark Ritchie (CFO) was granted PSP options over 736,842 Ordinary Shares, taking his total outstanding grants under the PSP scheme to options over 736,842 Ordinary Shares.

Neil Bird (Product Director), who is not on the Board but considered a Person Discharging Managerial Responsibilities, was granted PSP options over 447,368 Ordinary Shares, taking his total outstanding grants under the PSP scheme to options over 945,703 Ordinary Shares.

 

 

For further information, please contact:

Enteq Technologies plc +44 (0)20 8087 2202

www.enteq.com

Andrew Law, Chief Executive Officer

Mark Ritchie, Chief Financial Officer

 

Cavendish Capital Markets Limited (NOMAD and Broker) +44 (0)20 7220 0500

Ed Frisby, Fergus Sullivan (Corporate Finance)

Andrew Burdis, Barney Hayward (ECM)

 

 

 

 

 

 

 

 

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Andrew Law

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Enteq Technologies

b)

LEI

2138006BKS2MOAPRUB75

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Options over ordinary shares of 1 pence each

Identification code

GB00B41Q8Q68

b)

Nature of the transaction

Issue of options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

GBP 0.01

1,184,211

 

 

 

 

d)

Aggregated information

 

Not applicable - single transaction

e)

Date of the transaction

20 October 2023

f)

Place of the transaction

Outside a trading venue

 

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Ritchie

2.

Reason for the Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Enteq Technologies

b)

LEI

2138006BKS2MOAPRUB75

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Options over ordinary shares of 1 pence each

Identification code

GB00B41Q8Q68

b)

Nature of the transaction

Issue of options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

GBP 0.01

736,842

 

 

 

 

d)

Aggregated information

 

Not applicable - single transaction

e)

Date of the transaction

20 October 2023

f)

Place of the transaction

Outside a trading venue

 

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Neil Bird

2.

Reason for the Notification

a)

Position/status

Product Director

b)

Initial notification/Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Enteq Technologies

b)

LEI

2138006BKS2MOAPRUB75

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Options over ordinary shares of 1 pence each

Identification code

GB00B41Q8Q68

b)

Nature of the transaction

Issue of options

c)

Price(s) and volume(s)

Price(s)

Volume(s)

GBP 0.01

447,368

 

 

 

 

d)

Aggregated information:

 

Not applicable - single transaction

e)

Date of the transaction

20 October 2023

f)

Place of the transaction

Outside a trading venue

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFEDESEEDSELS
Date   Source Headline
10th Apr 20247:00 amRNSYear-end Trading Update
11th Jan 20249:12 amRNSHolding(s) in Company
8th Jan 20243:59 pmRNSHolding(s) in Company
24th Nov 20237:00 amRNSPresenting at the MelloLondon Conference
15th Nov 20237:00 amRNSHalf-year Report
2nd Nov 202310:25 amRNSDirector/PDMR Shareholding
30th Oct 20234:08 pmRNSResult of General Meeting
23rd Oct 20237:00 amRNSAwards under the Enteq Performance Share Plan
18th Oct 202311:07 amRNSInvestor Presentation via Investor Meet Company
10th Oct 20237:00 amRNSAppointment of Non-Executive Director
6th Oct 20232:25 pmRNSHolding(s) in Company
4th Oct 20237:00 amRNSHolding(s) in Company
29th Sep 20237:00 amRNSAGM Statement and Board Update
22nd Sep 20233:29 pmRNSNotice of Final Results
19th Sep 20232:53 pmRNSHolding(s) in Company
6th Sep 20237:00 amRNSNotice of Annual General Meeting
9th Aug 20238:25 amRNSSABER System Field Trial Update
31st Jul 20239:30 amRNSNotice of Final Results
1st Jun 20232:30 pmRNSIssue of Shares and Director/PDMR Shareholdings
1st Jun 20237:00 amRNSAppointment of new CFO
12th Apr 20237:00 amRNSSale of XXT and Year-end Trading Update
29th Mar 20237:08 amRNSSale of Property
15th Feb 20237:00 amRNSSABER Tool Update
16th Nov 20221:25 pmRNSDirector/PDMR Shareholding
16th Nov 20227:00 amRNSInterim Results
21st Sep 20223:36 pmRNSResult of AGM
21st Sep 20229:05 amRNSSecond Price Monitoring Extn
21st Sep 20229:00 amRNSPrice Monitoring Extension
21st Sep 20227:00 amRNSAGM Trading Statement
2nd Aug 20225:43 pmRNSIssue of Shares and Director/PDMR Shareholding
8th Jul 20223:10 pmRNSDirector/PDMR Shareholding
6th Jul 20227:00 amRNSFinal Results and Investor Presentation
14th Apr 20221:00 pmRNSDirector/PDMR Shareholding
7th Apr 20227:00 amRNSYear-end Trading Update
8th Mar 20229:06 amRNSHolding(s) in Company
3rd Mar 20221:47 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSBusiness Update and SABER Technology Progress
23rd Dec 202110:42 amRNSHolding(s) in Company
15th Dec 20213:39 pmRNSIssue of Shares and Director/PDMR Shareholding
18th Nov 20217:00 amRNSInterim Results
10th Nov 20217:00 amRNSExclusive Distributor Agreements Signed
8th Nov 20217:00 amRNSSABER Tool – Field Trial Update
28th Oct 20217:00 amRNSChange of Name
30th Sep 20214:05 pmRNSDirector/PDMR Shareholding
23rd Sep 20213:22 pmRNSResult of General Meeting and Change of Name
23rd Sep 20217:00 amRNSAGM Trading Statement
10th Aug 202110:30 amRNSDirector/PDMR Shareholding
26th Jul 20215:04 pmRNSDirector/PDMR Shareholding
14th Jul 20214:25 pmRNSIssue of shares and Director/PDMR Shareholding
7th Jul 20217:00 amRNSFinal Results & Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.